Aim: The objective of the present study was to design self nanoemulsifying drug delivery system of quetiapine fumarate by optimizing particle size, zeta potential, and drug release using response surface methodology. Materials and Methods: Self-nanoemulsified drug delivery system formulations were prepared using Labrafac Lipophile WL as oil, Tween 80 as a surfactant, and Capryol 90 as a cosurfactant. Pseudo-ternary phase diagrams of oil, surfactant/co surfactant, and water were developed using the water titration method. Different Smix ratios were prepared, and the maximum ratio was selected for self-nanoemulsified drug delivery system (SNEDDS) formulation. D-optimal design for 3 factors at 3 levels each was employed systematically to optimize particle size, zeta potential, and drug release. Result and Discussion: The polynomial mathematical model generated for response and found to be significant. The optimized model predicted a particle size 54.42 nm, zeta potential −13.03 mv, and drug release 93.67% residual plots for particle size, zeta potential, and % drug release indicates points nearly closed to straight lines indicating good model. The signal-to-noise ratio effect was studied which causes r 2 value closer to 0.5. Conclusion: The quantitative effect of these factors at different levels was predicted using polynomial equation. Response methodology was then used to predict the levels of the factors A, B, and C required to obtaining an optimum formulation. A new formulation was prepared according to these levels. Signalto-noise ratio was studied. Observed response was in close agreement with the predicted values of the optimized formulation, thereby demonstrating the feasibility of the optimization procedure in developing SNEDDS of quetiapine fumarate.
INTRODUCTION
O ral route has been the major preferred route of drug delivery for the chronic treatment of many diseases, due to convenience and improved patient safety, but approximately 35-40% of new drug candidates have poor aqueous solubility. The oral drug delivery of such drugs is frequently associated with low bioavailability, high inter and intrasubject variability, and lack of dose proportionality. [1, 2] Efforts are needed to enhance the oral bioavailability in the gastrointestinal (GI) tract. Currently, numerous methods utilized for drug solubility enhancement including solid dispersion, liposomes, polymer micelles, nanoemulsions, cyclodextrin inclusion, and self-emulsifying drug delivery system (SEDDS) are adopted to develop the oral drug delivery system because of their stability and possibility of easy oral administration to improve drug selfemulsification in the gut.
Self-nanoemulsifying systems are isotropic mixtures of natural or synthetic oils with lipophilic or hydrophilic surfactants which undergo spontaneously emulsification when exposed to the GI fluids to form o/w nanoemulsion. [3] Rapid emulsification of these systems under mild agitation in vivo generates high surface area, and thereby, increases the rate and extent of absorption and results in more reproducible blood time profiles. [4] In addition, lymphatic uptake of the drugs is enhanced due to the small globule size and surface charge associated with it. [5] Therefore, particle size, drug release and zeta potential were selected as optimization criteria.
However, such formulations, in general, are developed on trial and error approach of changing one variable at a time. By this conventional approach, it is possible to develop the formulation with specific characteristics; however, it is difficult to get the true optimum composition. [6] This methodology requires a large number of experiments to select excipients and also to analyze the effect of excipients on the formulations characteristics.
The statistical optimization design has been documented for the formulation of pharmaceutical solid dosage forms. Here, self-nanoemulsified drug delivery system (SNEDDS) was tried to optimize on the basis of particle size after dilution in double-distilled water which is profoundly influenced by several formulation variables. In the development of a SNEDDS, an important consideration is to design an optimized formulation with an appropriate particle size, zeta potential, and drug release, with a minimum number of trials. Statistical experimental design methodologies are powerful, efficient, and systematic tools in the design of pharmaceutical dosage forms, allowing rational study of the influence on formulation and/or processing parameters on the selected responses with a shortening of the experiment work. The main objective of the experimental design strategies is to plan experiments to obtain the maximum information regarding the considered experimental domain with the lowest numbers of experiments. Many statistical designs have been recognized as useful techniques to optimize the process variables. For this purpose, a computer-based optimization technique with a response surface methodology (RSM) utilizing a polynomial equation has been widely used. Different types of RSM design include 3level factorial design, central composite design, Box-Behnken design, and D-Optimal design. In RSM only a few significant factors are involved in optimization. The technique requires minimum experimentation and time, thus proving to be far more effective and cost-effective than conventional methods of formulating SNEDDS. [7, 8] As a type of quality by design, RSM is generally applied to experimental situations where several independent variables influence a response variable.
Quetiapine fumarate is a psychotropic agent belonging to a chemical class of dibenzothiazepine derivatives. It is a white or almost white powder, moderately soluble in water. Quetiapine fumarate is a BCS class II drug. It is reported to have very low oral bioavailability (9%). The half-life is only 6 h. [9] It is used to treat psychosis associated with Parkinson's disease and chronic schizophrenia. The antagonist activity of quetiapine fumarate at dopamine and serotonin receptors is mediated the antipsychotic effect. Quetiapine fumarate has also an antagonistic effect on the histamine H1 receptor. This is thought to be responsible for the sedative effect of the drug. It is used to treat psychosis associated with Parkinson's disease and chronic schizophrenia. These antipsychotics have a low incidence of extrapyramidal side effects and tardive dyskinesias compared to older antipsychotics. [9] [10] [11] Quetiapine fumarate is well absorbed and extensively metabolized following oral administration. The half-life is only 6 h. Quetiapine fumarate is approximately 83% bound to plasma proteins. Quetiapine fumarate is a weak acid with a dissociation constant (pK a )3.3 and 6.8 with moderate pH-dependent solubility, 94.3 mg/mL to 2.37 mg/mL at pH values from 1 to 9.
Due to its mood stabilizing effects, recently, quetiapine has gained attention as a treatment option in patients with bipolar affective disorder and major depression. Thus, the objective of the present paper was to evaluate, by means of response surface methodology, the influence of oil, surfactant, and cosurfactant on the particle size, zeta potential, and on drug release from SNEDDS. As a part of optimization process, the main effects, interaction effects, and quadratic effects of the formulation ingredients were evaluated for their effect on the particle size of quetiapine fumarate SNEDDS. Particle size is particularly important since release rates are greatly influenced by particle size. Zeta potential also confers stability of an emulsion.
MATERIALS AND METHODS

Materials
Quetiapine Fumarate was a received from Glenmark Pharmaceutical Pvt. Ltd., as a gift sample. Labrafac Lipophile WL 1349 and Capryol 90 were received as a gift sample from Gattefosse. All other chemicals/reagents were used of analytical grade and double-distilled water used throughout the experiments.
Preparation of the quetiapine fumarate self-nanoemulsifying formulation
A series of SNEDDS formulations was prepared using Tween 80/Capryol 90 as the surfactant/cosurfactant (S/CoS) combination and Labrafac Lipophile WL as the oil was given in [Tables 1 and 2 ]. In all the formulations, the level of the quetiapine fumarate was kept constant (25 mg). Briefly, accurately weighed the quetiapine fumarate was placed in a glass vial, and oil, surfactant, and co-surfactant were added. Then, the components were mixed by gentle stirring and vortex mixing and were heated at 40°C on a magnetic stirrer, and afterward, the mixture was sonicated on probe sonicator until the quetiapine fumarate was perfectly dissolved. The mixture was stored at room temperature until further study.
Determination of particle size
Particle size distribution following self-micro emulsification is a critical factor to evaluate a selfmicroemulsion system. The droplet size of the optimized formulation was measured using Zetasizer (Malvern Instrument, UK). The instrument generally works by photon correlation spectroscopy that measures the light scattering The particle size distribution and polydispersity index of various formulations are summarized in Table 3 . An increase in the concentration of the oil phase (Labrafac Lipophile WL 1349) resulted in a proportional increase in particle size because of the simultaneous decrease in the S/CoS proportion. Increasing the S/CoS ratio led to decrease in mean droplet size. It is well known that the addition of surfactants to the microemulsion system causes the interfacial film to stabilize and condense, while the addition of co-surfactant causes the film to expand; thus, the relative proportion of surfactant to co-surfactant has varied effects on the particle size.
Polydispersability index below 0.3 indicates good uniformity in the globule size distribution after dilution with water.
Determination zeta potential
The zeta potential indicates the degree of repulsion between adjacent, similarly charged particles in dispersion. For molecules and particles that are small enough, a high zeta potential will confer stability. The zeta potential of the optimized SNEDDS is given in Table 3 . 
In vitro dissolution study
All quetiapine fumarate SNEDDS formulation released study was carried out using dissolution apparatus paddle type using cellophane membrane with dissolution medium as 0.1 N hydrochloric acid, and all formulations approximately show release above 90% within 60 min as given in Table 3 . It could be suggested that the SNEDDS formulation resulted in spontaneous formation of a microemulsion with a small particle size, which permitted a faster rate of drug release into the aqueous phase. Thus, this greater availability of dissolved quetiapine fumarate from the selfmicroemulsifying drug delivery system formulation could lead to higher absorption and higher oral bioavailability. It was also showed that increase in surfactant concentration and decrease in oil concentration in formulation increase the drug release.
Experimental design
A 3 3 randomized full factorial design was applied in the present study. In the design, 3 factors were evaluated, each at 3 levels, and experimental trials were performed at all 27 possible combinations. These are usually referred to as low, intermediate, and high levels. These levels are numerically expressed as 0, 1, and 2 or −1, 0, and +1. A study, in which there are three factors with 3 levels, is called a 3 3 factorial design. The concentration of surfactant, concentration of cosurfactant, and concentration of oil were used as independent variables. The particle size, zeta potential, and drug release were used as dependent variables. The experimental design consists of a set of points lying at the midpoint of each edge and replicated center point of the multidimensional cube. The independent and dependent variables are listed in Table 1 . The polynomial equation generated by this experimental design (using design expert software version7.0) is as follows: Yi = b0 + b1X1 + b2X2 + b3X3 + b12X1X2 + b13X1X3 + b23X2X3 + b11X12 + b22X22 + b33 X32
Where Yi is the dependent variable, b0 is the intercept, b1 to b33 are the regression coefficients, and X1, X2, and X3 are the independent variable that was selected from the preliminary experiments. The model generated contained quadratic terms which explained the non-linear nature of responses and multiple factor terms explaining effects between factors. The formulation was optimized with the help of response surface diagram.
RESULTS AND DISCUSSION
Construction of phase diagram
Pseudo-ternary phase diagrams of oil, S/CoS, and water were developed using the water titration method. The mixtures of oil and S/CoS at certain weight ratios were diluted with water in a drop-wise manner. For each phase diagram at a specific ratio of S/CoS (i.e.,1:1, 2:1, 3:1, 1:2, and 1:3 wt/wt), a transparent and homogenous mixture of oil and S/CoS was formed by vortexing for 5 min. Then, each mixture was titrated with water and visually observed for phase clarity and flowability. The concentration of water at which turbidity-to-transparency and transparencyto-turbidity transitions occurred was derived from the weight measurements. These values were then used to determine the boundaries of the microemulsion domain corresponding to the chosen value of oils, as well as the S/CoS mixing ratio. To determine the effect of drug addiction on the microemulsion boundary, phase diagrams were also constructed in the presence of drug using drug-enriched oil as the hydrophobic component. Phase diagrams were then constructed using Chemix Software as shown in Figures 1-5 . Ratio 2:1 further selected as it shows maximum area and no separation of phases.
Optimization
Effect of excipients on drug release and model fitting
According to applied 3 3 experimental designs, 27 experiments were performed to optimize the formulation method of SNEDDS to get maximum drug release in terms of response. The obtained results were entered in design expert software 7.0.0 as shown in [ Table 4 ].
As shown in [ Table 4 ] the model F value of 2.58 implies that the model is statistically significant. There is only a 4.43% chance that a "model F value" this large could occur due to noise. Values of "P > F" <0.0500 indicate that model terms are statistically significant. In this case C, BC is significant model terms. The above final equation represents the independent variable quantitative effect and their interaction on the response. The values of the coefficients A, B, and C related to the effect of these variables on the response Y. Coefficient with more than one-factor term and those with higher order terms represent interaction term. A positive sign indicates a synergistic effect, while a negative sign indicates an antagonist effect.
Final equation in coded factors
Final equation in actual factors
Counter plot and three-dimensional (3D) graphical presentations 3D surface for drug release
Figures 6 and 7 show the counterplot and 3D surface, respectively, for Labrafac Lipophile, Tween 80, and Capryol 90. It appears as A and B concentration increases, % drug release was found to be increased at some level, and then, there is a decrease in % drug release as concentration of A and B increases at fixed level of C. Table 5 indicates the model F value of 2.83 implies that the model is statistically significant. There is only a 3.70 % chance that a "Model F value" this large could occur due to noise. Values of "Prob > F" <0.0500 indicate that model terms are statistically significant. In this case B, C is significant model terms [ Table 5 ]. individually. It appears as Labrafac Lipophile and Tween 80 increment, there is a decrease in particle size.
Effect of excipient on particle size
Effect of excipients on zeta potential
The model F value of 2.64 implies that the model is statistically significant. There is only a 4.76% chance that a "model F value" this large could occur due to noise. Values of "Prob > F" <0.0500 indicate that model BC is significant model terms [ Table 6 ]. individually. It was found that as Labrafac Lipophile and Tween 80 concentration increases, there was an increase in zeta potential. It was concluded from the graph that the factor A has a significant effect on the zeta potential.
Final equation in terms of coded factors
Optimization of formulation
For the model validation, the two formulations were prepared. The values of response predicted from the obtained model are shown in Table 7 , along with result obtained by experimentation. The close resemblance between observed and predicted response values assessed the robustness of 
CONCLUSION
Optimization of the SNEDDS formulation of quetiapine fumarate was performed using 3 factor, 3 level design. The amount of added A (Labrafil 2609 WL), B (Labrasol), and C (Cremophor EL) showed a significant effect on the particle size, drug release, and zeta potential.
The quantitative effect of these factors at different levels was predicted using polynomial equation. Response methodology was then used to predict the levels of the factors A, B, and C required to obtain an optimum formulation. A new formulation was prepared according to these levels. Signal-to-noise ratio was studied. Observed response was in close agreement with the predicted values of the optimized formulation, thereby demonstrating the feasibility of the optimization procedure in developing self-micro emulsifying delivery of quetiapine fumarate.
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